Top Markets
#1 DogBull DogBull +105.02%
#2 Siacoin Siacoin +53.17%
#3 ADO Protocol ADO Protocol +46.57%
#4 UnifAI Network UnifAI Network +44.82%
#5 MarsCoin MarsCoin +42.26%
#6 Useless Coin Useless Coin +23.51%
#7 Magma Finance Magma Finance +22.41%
#8 Ontology Gas Ontology Gas +20.59%
#9 Cash Cat Cash Cat +15.71%
#10 Apertum Apertum +14.51%
Coin of the day
DogBull DogBull
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Allgens Medical Technology Co. Ltd. Allgens Medical Technology Co. Ltd.

Allgens Medical Technology Co. Ltd.

688613
Classement en actions #16116
Allgens Medical Technology Co. Ltd. operates as a medical device firm,... Allgens Medical Technology Co. Ltd. operates as a medical device firm, concentrating on the development and production of sophisticated biomimetic synthetic bone graft systems. These innovative solutions are engineered for global deployment in areas where both cancellous (spongy) and cortical (dense outer layer) bone tissues have been compromised. The company's diverse product portfolio includes key offerings such as BonGold, a mineralized collagen scaffold designed for bone grafting procedures; the high-performance Alligator bone marrow aspirator; and OssaNova, a mineralized collagen-based material utilized for bone filling and augmentation. These products are broadly applied across a spectrum of orthopedic and skeletal repair interventions throughout the human anatomy. Allgens Medical Technology Co. Ltd. was established in 2004 and is headquartered in Beijing, China.
Prix de l'action
$2.28
Capitalisation boursière
$312.51M
Changement (1 jour)
0.70%
Changement (1 an)
-21.04%
Pays
CN
Échange Allgens Medical Technology Co. Ltd. (688613)

Catégorie

Healthcare
Revenus pour Allgens Medical Technology Co. Ltd. (688613)
Revenus en Sep 2026 TTM : 0
Selon les derniers rapports financiers de Allgens Medical Technology Co. Ltd., le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Allgens Medical Technology Co. Ltd. de 2026 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
Pas assez de données pour les dates fournies.
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US